TY - JOUR
T1 - Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis
T2 - A Delphi consensus among Italian experts
AU - Armuzzi, Alessandro
AU - Felice, Carla
AU - Lubrano, Ennio
AU - Cantini, Fabrizio
AU - Castiglione, Fabiana
AU - Gionchetti, Paolo
AU - Orlando, Ambrogio
AU - Salvarani, Carlo
AU - Scarpa, Raffaele
AU - Marchesoni, Antonio
AU - Vecchi, Maurizio
AU - Olivieri, Ignazio
PY - 2017
Y1 - 2017
N2 - Background: Treatment of patients with coexisting spondyloarthritis (SpA) and inflammatory bowel disease (IBD) often requires multidisciplinary collaboration between gastroenterologists and rheumatologists. Aim: To describe the results of the first Delphi consensus to define shared therapeutic strategies for the best management of patients with coexisting SpA and IBD. Methods: A scientific steering committee of 10 Italian experts in the field of SpA and IBD developed 27 statements on 5 possible clinical scenarios and selected 40 specialists from across Italy, both gastroenterologists and rheumatologists, to vote them using a Delphi method. Each participant expressed a level of agreement on each statement using a 5-point scale (1 = "absolutely disagree"; 5 = "absolutely agree"). Total cumulative agreement was defined as the sum of the percentage of responses to items 4 ("agree") and 5 ("absolutely agree"). Total cumulative agreement ≥70% defined consensus for each statement. Results: After the first round, positive consensus was reached for 22 statements. Statements without consensus were discussed in a plenary session before the second vote. Positive consensus was then reached in all statements, with final total cumulative agreement ranging from 80% to 100%. Conclusion: This is the first Delphi consensus defining specific treatment algorithms for patients with coexisting SpA and IBD.
AB - Background: Treatment of patients with coexisting spondyloarthritis (SpA) and inflammatory bowel disease (IBD) often requires multidisciplinary collaboration between gastroenterologists and rheumatologists. Aim: To describe the results of the first Delphi consensus to define shared therapeutic strategies for the best management of patients with coexisting SpA and IBD. Methods: A scientific steering committee of 10 Italian experts in the field of SpA and IBD developed 27 statements on 5 possible clinical scenarios and selected 40 specialists from across Italy, both gastroenterologists and rheumatologists, to vote them using a Delphi method. Each participant expressed a level of agreement on each statement using a 5-point scale (1 = "absolutely disagree"; 5 = "absolutely agree"). Total cumulative agreement was defined as the sum of the percentage of responses to items 4 ("agree") and 5 ("absolutely agree"). Total cumulative agreement ≥70% defined consensus for each statement. Results: After the first round, positive consensus was reached for 22 statements. Statements without consensus were discussed in a plenary session before the second vote. Positive consensus was then reached in all statements, with final total cumulative agreement ranging from 80% to 100%. Conclusion: This is the first Delphi consensus defining specific treatment algorithms for patients with coexisting SpA and IBD.
KW - Delphi method
KW - Inflammatory bowel disease
KW - Integrated management
KW - Spondyloarthritis
KW - Therapy
UR - http://www.scopus.com/inward/record.url?scp=85027466858&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85027466858&partnerID=8YFLogxK
U2 - 10.1016/j.dld.2017.06.004
DO - 10.1016/j.dld.2017.06.004
M3 - Article
AN - SCOPUS:85027466858
JO - Digestive and Liver Disease
JF - Digestive and Liver Disease
SN - 1590-8658
ER -